Kumar Neil bought MAZE
March 27, 2026 · Form 4 insider transaction
Kumar Neil bought 33,417 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,417
Price
$0.00
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 27, 2026
Filing dateMarch 31, 2026
Shares owned after33,417
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on April 27, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.